We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

121 hedge funds and large institutions have $72.6M invested in Ampio Pharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

728% more call options, than puts

Call options by funds: $1.94M | Put options by funds: $234K

11% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 28

3% less capital invested

Capital invested by funds: $75.2M → $72.6M (-$2.58M)

5% less funds holding

Funds holding: 128 → 121 (-7)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
121
Holders Change
-7
Holders Change %
-5.47%
% of All Funds
2.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
31
Reduced
28
Closed
13
Calls
$1.94M
Puts
$234K
Net Calls
+$1.7M
Net Calls Change
-$599K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$978K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$567K
3
BJL
Brighton Jones LLC
Washington
+$307K
4
BlackRock
BlackRock
New York
+$225K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$204K

Top Sellers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
-$763K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$524K
3
Jane Street
Jane Street
New York
-$283K
4
SFS
Strategic Financial Services
New York
-$278K
5
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$239K
Name Holding Trade Value Shares
Change 		Change in
Stake
MFW
101
Mosaic Family Wealth
Missouri
$18K – – –
SFS
102
Strategic Financial Services
New York
$17K -$278K -600 -95%
FWM
103
Focused Wealth Management
New York
$17K – – –
H
104
HoyleCohen
California
$17K – – –
PAG
105
Private Advisor Group
New Jersey
$17K – – –
WTFG
106
Wells Trecaso Financial Group
Ohio
$17K – – –
WA
107
WealthTrust Axiom
Pennsylvania
$16K – – –
WP
108
WealthPLAN Partners
Nebraska
$15K – – –
TRCT
109
Tower Research Capital (TRC)
New York
$13K -$6.03K -13 -33%
Northwestern Mutual Wealth Management
110
Northwestern Mutual Wealth Management
Wisconsin
$13K – – –
Wells Fargo
111
Wells Fargo
California
$12K -$2.32K -5 -18%
NFSG
112
Newbridge Financial Services Group
Florida
$11K – – –
TFS
113
TrustCore Financial Services
Tennessee
$10K – – –
Bank of America
114
Bank of America
North Carolina
$8K +$927 +2 +13%
UBS Group
115
UBS Group
Switzerland
$8K +$6.49K +14 +467%
AF
116
Allworth Financial
California
$3K – – –
CTB
117
Country Trust Bank
Illinois
$3K – – –
MA
118
MUFG Americas
New York
$3K – – –
CAGAS
119
Capital Advisory Group Advisory Services
Minnesota
$2K – – –
GEA
120
Glen Eagle Advisors
New Jersey
$1.66K – – –
MAWCM
121
Mine & Arao Wealth Creation & Management
California
$1K – – –
First Trust Advisors
122
First Trust Advisors
Illinois
– -$763K -1,524 Closed
Balyasny Asset Management
123
Balyasny Asset Management
Illinois
– -$101K -202 Closed
CSS
124
Cubist Systematic Strategies
Connecticut
– -$62K -124 Closed
CM
125
Caption Management
Oklahoma
– -$55K -108 Closed
2 3 4
5
6

AMPE Hedge Fund Activity: Q3 2021 in Review

121 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2021, worth a combined $72.6M — down 3.4% from $75.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AMPE and 7 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 31 added.

The largest buyer was State Street, adding an estimated $978K. The largest seller was First Trust Advisors, exiting entirely with an estimated $763K sold.

  • 121 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2021, down from 128 in Q2 2021.
  • Funds reported $72.6M of Ampio Pharmaceuticals Inc. stock for Q3 2021, down 3.4% quarter-over-quarter.
  • 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2021 and 13 closed out, a net change of -6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2021 was State Street, an estimated $978K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2021 was First Trust Advisors, an estimated $763K sold.

Based on aggregated 13F filings for Q3 2021.